FROM THE FAMILY PRACTICE INQUIRIES NETWORK
Do Vitamin C Supplements Reduce Cardiovascular Disease Mortality?
FREE PREVIEW Log in or buy this issue to read the full article. AAFP members and paid subscribers get free access to all articles. Subscribe now.
FREE PREVIEW Subscribe or buy this issue. AAFP members and paid subscribers get free access to all articles.
Am Fam Physician. 2004 Apr 1;69(7):1723-1724.
Do vitamin C supplements reduce mortality in patients with cardiovascular disease?
Vitamin C, when taken as a dietary supplement, does not appear to reduce mortality in patients with cardiovascular disease. [Strength of recommendation: B, based on reviews of cohort studies and a single randomized controlled trial (RCT)]
It has been suggested that antioxidant nutrients, such as vitamin C, may play a role in reducing cardiovascular disease. Several cohort studies and one RCT have evaluated the effectiveness of antioxidants in reducing mortality associated with cardiovascular disease.1–5 [References1 through4—Level of evidence: 1A, based on systematic review of cohort studies]
Seven large cohort studies involving more than 4,000 patients assessed various antioxidants and their effect on cardiovascular disease mortality.3 Dosages were different in the studies, and the results were inconsistent. Only two of these studies showed a relative risk reduction (RR).
The first of these two studies, the National Health and Nutrition Examination Survey (NHANES), included 11,348 patients who were taking more than 50 mg of vitamin C per day, which resulted in an RR of 48 percent (range: 31 to 61 percent) in cardiovascular disease mortality. The second of the two studies included 5,133 patients in Finland who were taking more than 90 mg of vitamin C per day, which resulted in an RR of 51 percent (range: 2 to 68 percent).
The remaining five studies included 102,735 patients taking various doses of vitamin C but showed no effect on cardiovascular disease mortality.2 The Chinese Cancer Prevention Trial5 (the only completed RCT of vitamin C) studied 39,584 patients who were taking more than 250 mg of vitamin C per day. This study demonstrated no effect on prevention of cardiovascular disease mortality.
Several clinical trials involving thousands of patients are currently examining major cardiovascular events (e.g., myocardial infarction) and mortality, and the use of antioxidants for prevention of cardiovascular disease. It is hoped that the results of these trials will further elucidate the role of antioxidant supplementation in treating and preventing cardiovascular disease.2
The U.S. Preventive Services Task Force (USPSTF) conducted a systematic review of the studies on vitamin C and found the evidence inconclusive because the studies were inadequate and conflicting.1
Recommendations from Others
According to the USPSTF, there is insufficient evidence to recommend vitamin supplements for the prevention of cardiovascular disease.1 The American Heart Association recommends a diet rich in antioxidants but concludes that there is insufficient evidence for any specific recommendations for vitamin supplementation.6
Many primary care physicians and cardiologists continue to recommend vitamin C for prevention of cardiovascular disease mortality, so you may encounter some resistance from patients if you decline to support this supplementation. In situations like this, it may be helpful to explain that while we once thought it was a good idea, newer studies have shown that it “just didn't pan out.”
Address correspondence to Doug Aukerman, M.D., Pennsylvania State University, Milton S. Hershey Medical Center, 1850 E. Park Ave., Suite 112, University Park, PA 16803 ( email@example.com). Reprints are not available from the author.
1. U.S. Preventive Services Task Force. Routine vitamin supplementation to prevent cancer and cardiovascular disease: recommendations and rationale. Rockville, Md.: Agency for Healthcare Research and Quality, 2003. Accessed February 18, 2004, at http://www.ahrq.gov/clinic/3rduspstf/vitamins/vitaminsrr.htm.
2. Morris CD, Carson S. Routine vitamin supplementation to prevent cardiovascular disease. A summary of the evidence for the U.S. Preventive Services Task Force. Rockville, Md.: Agency for Healthcare Research and Quality, 2003. Accessed February 18, 2004, at http://www.ahrq.gov/clinic/3rduspstf/vitamins/vitcvdsum.htm.
3. Jha P, Flather M, Lonn E, Farkouh M, Yusuf S. The antioxidant vitamins and cardiovascular disease. A critical review of epidemiologic and clinical trial data. Ann Intern Med. 1995;123:860–72.
4. Asplund K. Antioxidant vitamins in the prevention of cardiovascular disease: a systematic review. J Intern Med. 2002;251:372–92.
5. Blot WJ, Li JY, Taylor PR, Guo W, Dawsey S, Wang GQ, et al. Nutrition intervention trials in Linxian, China: supplementation with specific vitamin/mineral combinations, cancer incidence, and disease-specific mortality in the general population. J Natl Cancer Inst. 1993;85:1483–92.
6. Tribble DL. AHA science advisory. Antioxidant consumption and risk of coronary heart disease: emphasis on vitamin C, vitamin E, and beta-carotene: a statement for healthcare professionals from the American Heart Association. Circulation. 1999;99:591–5.
Copyright Family Practice Inquiries Network. Used with permission.
Clinical Inquiries provide answers to questions submitted by practicing family physicians to the Family Practice Inquiries Network (FPIN). Members of the network select questions based on their relevance to family medicine. Answers are drawn from an approved set of evidence-based resources and undergo peer review. The strength of recommendations and the level of evidence for individual studies are rated using criteria developed by the Evidence-Based Medicine Working Group ( http://www.cebm.net/levels_of_evidence.asp).
This series of Clinical Inquiries is coordinated for American Family Physicianby John Epling, M.D., State University of New York Upstate Medical University, Syracuse, N.Y. The complete database of evidence-based questions and answers is copyrighted by FPIN.
Copyright © 2004 by the American Academy of Family Physicians.
This content is owned by the AAFP. A person viewing it online may make one printout of the material and may use that printout only for his or her personal, non-commercial reference. This material may not otherwise be downloaded, copied, printed, stored, transmitted or reproduced in any medium, whether now known or later invented, except as authorized in writing by the AAFP. Contact firstname.lastname@example.org for copyright questions and/or permission requests.
Want to use this article elsewhere? Get Permissions